T. Ikeda

Sequential Therapy with Crizotinib and Alectinib in ALK‐Rearranged Non–Small Cell Lung Cancer—A Multicenter Retrospective Study

E. Gabazza, N. Yamamoto, Kentaro Fujiwara, 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phase I/II and pharmacologic study of irinotecan and carboplatin for patients with lung cancer

H. Saka, M. Ando, Y. Hasegawa, 2001, Cancer Chemotherapy and Pharmacology.

Phenotypic and functional analyses of natural killer cells: Impaired NK activity partly due to the CD56+ cell dysfunction in cancer patients

T. Kishida, K. Uno, A. Kishi, 1999 .